RxDoctor Payments Data

James Meeks, DO

Psychiatry · Jacksonville, FLNPI 1740608983

Payments from drug & device makers

$1,646in general payments, 2019–2025

Across 85 payments — averaging $19.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$403
  • Neos Therapeutics, LP$172
  • Otsuka America Pharmaceutical, Inc.$168
  • Johnson & Johnson$153
  • Lundbeck LLC$130
  • Corium, LLC$104
  • plus $516 from 12 others

What the payments were for

  • Food & beverage$1,646100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,646 in reported general payments places this provider in the 65th percentile of 2,059 psychiatry providers in Florida.

See all psychiatry providers in Florida

Medicare billing

Part B allowed, 2024
$85,945
Medicare patients
127
Services billed
853

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl42$60,692
Desvenlafaxine Succinate ErDesvenlafaxine Succinate40$4,514
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine103$3,624
Clonazepam260$3,273
Lisdexamfetamine Dimesylate12$2,966
Aripiprazole100$2,614
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine49$2,281
Bupropion XlBupropion Hcl91$2,168
Methylphenidate Hcl81$1,713
Fluvoxamine Maleate11$1,703
Lamotrigine93$1,591
Quetiapine Fumarate73$1,488
Alprazolam219$1,311
Duloxetine Hcl54$1,274
Mirtazapine62$1,045

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$403$60,69242 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,059 psychiatry providers in Florida.

Other psychiatry in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →